• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

261.6599 USD 3.7301 1.41%

As of 20:04:05 ET on 12/22/2014.

Snapshot for Actavis plc (ACT)

Open: 264.3800 Day's Range: 259.0200 - 265.5900 Volume: 1,895,631
Previous Close: 265.3900 52wk Range: 163.6700 - 272.7500 1-Yr Rtn: +57.66%

Stock Chart for ACT

No chart data available.
  • ACT:US 261.6600
  • 1D
  • 1M
  • 1Y
265.3900
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 51.1793
Estimated P/E(12/2014) 19.2737
Relative P/E vs. SPX 2.7802
Earnings Per Share (USD) (ttm) 5.1126
Est. EPS (USD) (12/2014) 13.5760
Est. PEG Ratio 1.0023
Market Cap (M USD) 69,355.89
Shares Outstanding (M) 265.06
30 Day Average Volume 3,710,357
Price/Book (mrq) 2.3786
Price/Sale (ttm) 4.3219
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
Maria Teresa Hilado "Tessa"Chief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil